Literature DB >> 19787227

Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase.

Ping Cheng1, Yuhua Li, Liping Yang, Yanjun Wen, Wei Shi, Yongqiu Mao, Ping Chen, Huimin Lv, Qingqing Tang, Yuquan Wei.   

Abstract

Hepatitis B virus X protein (HBx) is a multi-functional regulatory protein that is known to be involved in viral proliferation, transcriptional activation and cell growth control. However, the actual role of HBx in cell growth control remains controversial. In this study, the impact of HBx on cell growth in vitro and in vivo was further investigated. HBx was able to inhibit the growth of hepatocellular carcinoma (HCC) cells and induce G2/M arrest in vitro. Moreover, unlike many other G2/M arrest mechanisms, HBx did not inhibit cyclin B1-CDK1 kinase activity, but it persistently activated the cyclin B1-CDK1 kinase. In vivo, HBx inhibited tumor cell growth and induced apoptosis as well as inhibited the growth of vascular endothelial cells. In conclusion, HBx induced G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase, and negatively regulated cell growth in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787227     DOI: 10.3892/or_00000542

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  27 in total

Review 1.  Hepatitis B virus X gene and hepatocarcinogenesis.

Authors:  Sue-Ann Ng; Caroline Lee
Journal:  J Gastroenterol       Date:  2011-06-08       Impact factor: 7.527

2.  Enterovirus 71 3C Promotes Apoptosis through Cleavage of PinX1, a Telomere Binding Protein.

Authors:  Jing Li; Yunfang Yao; Yu Chen; Xiao Xu; Yongquan Lin; Zhilong Yang; Wentao Qiao; Juan Tan
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Authors:  Yuchen Xia; Xiaoming Cheng; Yao Li; Kristin Valdez; Weiping Chen; T Jake Liang
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 4.  CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Authors:  Paul Dent; Yong Tang; Adly Yacoub; Yun Dai; Paul B Fisher; Steven Grant
Journal:  Mol Interv       Date:  2011-04

5.  Adenoviral gene therapy in hepatocellular carcinoma: a review.

Authors:  Iván Lyra-González; Laura Esther Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  Hepatol Int       Date:  2012-04-25       Impact factor: 6.047

6.  Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH.

Authors:  Ishtiaq Qadri; Kaneez Fatima; Hany AbdeL-Hafiz
Journal:  BMC Microbiol       Date:  2011-03-04       Impact factor: 3.605

7.  Vitamin A-coupled liposomes carrying TLR4-silencing shRNA induce apoptosis of pancreatic stellate cells and resolution of pancreatic fibrosis.

Authors:  Yuwei Zhang; Dan Yue; Liuliu Cheng; Anliang Huang; Nanwei Tong; Ping Cheng
Journal:  J Mol Med (Berl)       Date:  2018-03-27       Impact factor: 4.599

8.  The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation.

Authors:  Xiaoyu Fu; Deming Tan; Zhouhua Hou; Zhiliang Hu; Guozhen Liu; Yi Ouyang; Fei Liu
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

9.  The therapeutic effects and mechanisms of Long Chai Fang on chronic hepatitis B.

Authors:  Tingting Xu; Pei Wang; Xue Zheng; Zhanpeng Yan; Kun Li; Jindi Xu; Cuihua Jiang; Fangshi Zhu
Journal:  Ann Transl Med       Date:  2021-05

10.  Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells.

Authors:  Yun-Ju Chen; Pei-Hsuan Chien; Wen-Shu Chen; Yu-Fong Chien; Ya-Ying Hsu; Li-Yun Wang; Jhen-Yu Chen; Chih-Wen Lin; Tzung-Chi Huang; Yung-Luen Yu; Wei-Chien Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.